ONCY

#3958
Oncolytics Biotech, Inc. Common Shares
1.12 USD
+5.66%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.12
1.12
년간 변동
0.33
1.51
일일 변동
+5.66%
월간 변동
+13.13%
6달 변화
-5.88%
년간 변동율
+96.49%
이전 종가
1.06
Open
1.12
Bid
Ask
Low
1.12
High
1.12
양
3
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 130.06 M
  • Employee 29
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DVS826
  • Industry 생명공학
총매출
Net income
Total debt
Free cash flow
Cash & equivalents

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

뉴스